The molecular mechanisms by which etomoxir and orlistat inhibited proliferation in myeloma cells is associated to reduce p21 protein levels and phosphorylation levels of pRb, two key proteins involved in G1/S cell cycle progression. The gene discussed is RB1; the disease is plasma cell myeloma.